Vaccinia Capping System - 400 units

Supplied by New England Biolabs


  • M2080S | Vaccinia Capping System 400 units
  • M2080S | Vaccinia Capping System 400 units
Average lead time: 5 to 7 Days
Need Assistance?

Jump to Section
Product Description

Vaccinia Capping System provides the necessary components to add 7-methylguanylate cap structures (Cap 0) to the 5' end of RNA. In eukaryotes, these terminal cap structures are involved in stabilization, transport, and translation of mRNAs. Enzymatic production of capped RNA is an easy way to improve the stability and translational competence of RNA used for in vitro translation, transfection, and microinjection. Alternatively, use of labeled GTP in a reaction provides a convenient way to label any RNA containing a 5' terminal triphosphate. Vaccinia capping enzyme is composed of two subunits (D1 and D12). The D1 subunit carries three enzymatic activities (RNA triphosphatase, guanylyltransferase and guanine methyltransferase); all necessary for addition of a complete Cap 0 structure, m7Gppp5'N to 5' triphosphate RNA. In vitro transcripts can be capped in less than one hour in the presence of the capping enzyme, reaction buffer, GTP, and the methyl donor, SAM.
Specifications
Inventory Number:
NEBM2080SEA
Part Number:
M2080S
Supplier:
New England Biolabs
Supplier's Lead Time:
5 to 7 Days
Quantity:
1 per EA
Contract Availability:
Country of Origin:
United States
Additional Information

Contact the GSS Team Today!
GSS-Sales@govsci.com | 800.248.8030 | www.govsci.com

Government Scientific Source
ISO 9001:2015 Certified
Copyright 2025, Government Scientific Source. All Rights Reserved.